Glp-1 Medications and Glp-1/GIP Medications are prescription medications that are prescribed for weight loss and Type 2 Diabetes. They belong to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. They mimic the action of GLP-1, a hormone that stimulates the release of insulin and reduces the amount of glucose produced by the liver. This helps lower blood sugar levels in people with diabetes. Glp-1 Medications and Glp-1/GIP Medications also reduce the speed at which food passes through the digestive system. Glp-1 Medications and Glp-1/GIP Medications prolong digestion, helping to maintain your feeling of fullness for a longer period. Therefore, when you take Glp-1 Medications and Glp-1/GIP Medications injections, you feel fuller faster and are less likely to overeat. This allows most people to lose up to 15% of their bodyweight or more over a number of months.
Same Active Ingredient as Big Brands
Lose up to 15% of Your Bodyweight
Easy to Administer Weekly Shot
Feel Fuller Faster & Longer
Compounding Pharmacy Custom Dose
A study of 2,000 obese adults compared people using Glp-1 Medications plus a diet and exercise program with people who made the same lifestyle changes without Glp-1 Medications. After 68 weeks, half of the participants using Glp-1 Medications lost 15% of their body weight, and nearly a third lost 20%. Participants who incorporated only lifestyle changes lost only about 2.4% of their body weight.
Glp-1 Medications has significant weight loss, averaging a 14.9% reduction from initial body weight without restrictive diet or intense exercise. Additionally, one-third of patients who used Glp-1 Medications lost at least 20% of baseline weight, representing a 60-pound weight loss for a 300-pound individual.
Same Active Ingredient as Big Brands
Lose up to 15% of Your Bodyweight
Easy to Administer Weekly Shot
Feel Fuller Faster & Longer
Compounding Pharmacy Custom Dose
A study of over 600 obese adults using Glp-1/GIP Medications showed that over 80% of participants lost greater than 15% of their body weight. Additionally, over 36% of participants lost greater than 25% of their body weight when taking the higher dose of Glp-1/GIP Medications.
Research studies have demonstrated that patients on Glp-1/GIP Medications have significant weight loss, averaging a 20.9% reduction from initial body weight without restrictive diet or intense exercise. Additionally, one-third of patients who used Glp-1/GIP Medications lost at least 25% of baseline weight, representing a 75-pound weight loss for a 300-pound patient.
Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain are common side effects, especially when starting the medication. These symptoms often improve over time.
Hypoglycemia: While Glp-1/GIP Medications themselves are less likely to cause low blood sugar (hypoglycemia) when used alone, combining it with other medications that lower blood sugar or insulin can increase the risk of hypoglycemia.
Injection Site Reactions: Some individuals may experience redness, swelling, or itching at the injection site.
Thyroid Tumors: In animal studies, Glp-1/GIP Medications have been associated with an increased risk of thyroid tumors. It's essential to discuss any concerns with your healthcare provider, who can assess the risks and benefits for your specific situation.
Pancreatitis: There have been reports of pancreatitis (inflammation of the pancreas) with GLP-1 receptor agonists. Inform your doctor if you experience severe abdominal pain.
Allergic Reactions: While rare, allergic reactions such as rash, itching, or severe dizziness can occur. Seek medical attention if you experience these symptoms.